Associated Papers
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.
Bagyinszky E et al.
Cells, 2023
ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia.
Wang Y et al.
Frontiers in Neurology, 2022
Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants.
Sung W et al.
Brain Communications, 2022
ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics.
Nahm M et al.
Science Translational Medicine, 2020
Theme 3 In vitro experimental models.
Yang S et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2019
Select a paper to view details